Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A stock certificate on an office desk with scattered papers

May 23, 2026

Wave Life Sciences (WVE) Valuation Check After Sharp Share Price Weakness

Wave Life Sciences has experienced significant stock price volatility, closing at $6.38, with a notable 60% decline year-to-date and 52.71% over the last 90 days. Despite these short-term losses, the company has shown a mixed performance in total shareholder returns, achieving 7.23% over one year and 74.32% over three years.With a revenue of $71.8 million and a net loss of $183.6 million, the question arises whether the current share price reflects an undervalued opportunity or if future growth
A blood sample in a test tube on a lab bench

May 23, 2026

Europe In-Vitro Diagnostics (IVD) Market to Reach USD 34.47 Billion by 2033 as Advanced Diagnostics and Aging Population Drive Demand

The European In-Vitro Diagnostics (IVD) market is projected to reach USD 34.47 billion by 2033, driven by an aging population and advancements in diagnostic technologies.The IVD sector encompasses tests conducted on biological samples to diagnose diseases and monitor health conditions. This market is notably advanced in Europe, where countries like Germany, France, and the UK lead due to robust healthcare systems and a focus on early disease detection. The growing emphasis on personalized medici
A minimalist illustration of a coin representing cash dividends in a dark palette.

May 23, 2026

Is Quest’s Strong Q1 Beat and Raised 2026 Outlook Altering The Investment Case For Quest Diagnostics (DGX)?

Quest Diagnostics has reported a strong performance in Q1 2026, exceeding analyst expectations with adjusted earnings per share of $2.50 and revenues of $2.90 billion, driven by a notable 10.9% increase in testing volumes. The company has also revised its full-year outlook for 2026, projecting higher revenue and earnings, which has implications for its investment narrative.The reaffirmation of a quarterly cash dividend of $0.86 per share reflects management's confidence in the company's financia
A smart inhaler on a clinical table with a stethoscope in the background.

May 23, 2026

Chronic Obstructive Pulmonary Disease (COPD) Market Expands with Smart Inhalers, AI Diagnostics, and Advanced Respiratory Therapies

The Chronic Obstructive Pulmonary Disease (COPD) market is undergoing significant expansion, driven by advancements in digital health technologies and a growing emphasis on effective disease management.The global COPD market is projected to grow from approximately $27.53 billion in 2025 to $51.17 billion by 2034, reflecting a compound annual growth rate (CAGR) of 7.13%. This growth is fueled by rising rates of respiratory disorders and the increasing integration of digital health solutions, incl
Minimalist illustration of dental equipment

May 23, 2026

United States Dental Equipment Market Expands with Rapid Digital Dentistry Adoption and AI-Powered Diagnostics

The U.S. dental equipment market is experiencing significant growth driven by the rapid adoption of digital technologies and AI-powered diagnostics. Forecasts suggest the market will increase from $3.96 billion in 2025 to $6.65 billion by 2034, reflecting a compound annual growth rate (CAGR) of 5.93%.This expansion is largely attributed to the transition from traditional methods to digital workflows, enhancing diagnostic precision and treatment efficiency. Key technologies such as intraoral scan
A banana plant in front of the Geneo life sciences hub in Singapore.

May 23, 2026

New life sciences hub to foster collaboration in Singapore

The newly launched Geneo life sciences hub in Singapore is poised to enhance collaboration and innovation in the sector.Located in Science Park, Geneo aims to create a dynamic ecosystem for both established firms and startups in the life sciences industry. Officially opened by CapitaLand, the hub encompasses three properties with a significant portion dedicated to biomedical research and development. With over 80% of its space already occupied, it is attracting multinational companies like Barry
MRI scan of a brain in a hospital corridor

May 23, 2026

AI-powered brain health project gets $30m boost

The Australian Epilepsy Project (AEP) has received a significant $30 million funding boost from the Federal Government, aimed at integrating its advanced brain health platform into the Australian healthcare system.This funding will enhance access to innovative diagnostics for clinicians and hospitals, thereby improving the speed and quality of care for Australians suffering from epilepsy and other neurological conditions. Established in 2021 with an initial investment of $30 million, the AEP uti
A minimalist illustration of a surgical implant and tool on a dark background.

May 23, 2026

Futura Medtech Expands Medtech Platform, Invests in Bengaluru-based Rivarp Medical

Futura Medtech has announced a strategic investment in Bengaluru-based Rivarp Medical, expanding its medtech platform to include devices and implants for orthopedics, neurosurgery, and interventional cardiology.This investment is part of Jashvik Capital's broader strategy to develop a diverse medical device business with both domestic and international reach. Rivarp Medical, established in 2016, has created a robust product portfolio and has gained significant regulatory approvals, including EU
Construction site of a new hospital in Lucknow

May 23, 2026

Max Healthcare to Set Up Lucknow Facility with INR 1,400 Cr Investment

Max Healthcare is set to invest ₹1,400 crore in a new facility in Lucknow, reflecting its commitment to enhancing healthcare services in tier-2 cities.This significant investment aims to bolster Max Healthcare's hospital capacity in North India, addressing the increasing demand for advanced medical services in the region. The decision aligns with the company's broader strategy to expand its healthcare infrastructure, particularly in Uttar Pradesh, where the population growth is driving a need fo
A dollar sign and light bulb representing venture capital and innovation

May 23, 2026

Australia Venture Capital Investment Market: Fueling Innovation and High-Growth Startups

The Australian venture capital investment landscape is rapidly evolving, positioning itself as a significant driver of innovation across various sectors, including healthcare and technology. As reported by the IMARC Group, the market is estimated to have reached USD 9.5 billion in 2024, with projections indicating a substantial increase to USD 38.9 billion by 2033, reflecting a robust compound annual growth rate (CAGR) of 15.2% during the period from 2025 to 2033.This growth underscores Australi
A surgical scalpel and gloves in an operating room

May 23, 2026

Zacks Industry Outlook Highlights Electromed, Globus Medical and Intuitive Surgical

The integration of generative AI (GenAI) in the medical instruments sector is gaining momentum, with companies like Electromed, Globus Medical, and Intuitive Surgical at the forefront of this transformation.Recent advancements in GenAI have shifted from experimental phases to practical applications within the medical instruments industry. These technologies are now utilized for generating synthetic medical images, simulating disease progression, and aiding in drug development processes. A McKins
A minimalist representation of a coin symbolizing startup funding.

May 23, 2026

EU-Startups Reports Weekly European Startup Funding

EU-Startups recently provided a summary of key funding activities across Europe during the week of May 18-22, 2026, emphasizing the robust nature of the startup ecosystem in the region.Among the standout funding events, UK-based Primer, a payments startup, successfully raised €86.2 million in a Series C funding round aimed at bolstering its AI capabilities and expanding its presence in the US market. In a related move, Málaga's Magnific initiated a €10 million fund to assist creative teams in tr